Dr. Jason B. Wynberg, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 743 Jefferson Ave, Scranton, PA 18510 Phone: 570-491-8141 Fax: 570-891-4284 |
Matthew Loecher, MD Urology Medicare: Medicare Enrolled Practice Location: 300 Lackawanna Ave Ste 200, Scranton, PA 18503 Phone: 570-342-7864 |
Dr. Ira Joel Kohn, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 475 Morgan Hwy, Scranton, PA 18508 Phone: 570-703-2440 Fax: 570-703-2451 |
Dr. J. Robert Ramey, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 475 Morgan Hwy, Scranton, PA 18508 Phone: 570-703-2440 Fax: 570-703-2451 |
Eric Charles Rottenberg, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 300 Lackawanna Ave Ste 200, Scranton, PA 18503 Phone: 610-402-6986 Fax: 570-348-6795 |
Mr. Raju Chelluri, Urology Medicare: Medicare Enrolled Practice Location: 300 Lackawanna Ave Ste 200, Scranton, PA 18503 Phone: 570-342-7864 |
Dr. Brian Butler Kapp, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 475 Morgan Hwy, Scranton, PA 18508 Phone: 570-703-2440 Fax: 570-703-2415 |
Dr. Jerald Blair Gilbert, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 475 Morgan Hwy, Scranton, PA 18508 Phone: 570-703-2440 Fax: 570-703-2451 |
Dr. Donald L. Preate Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 300 Lackawanna Ave Ste 200, Scranton, PA 18503 Phone: 570-342-7864 Fax: 570-588-3588 |
News Archive
Depression in both expectant mothers and fathers increases the risk of premature birth, finds a study published in BJOG: an International Journal of Obstetrics and Gynaecology (BJOG).
A new study from LSU's Pennington Biomedical Research Center showed for the first time that video games, in combination with fitness coaching and a step tracker, helped overweight children lose weight, lower their blood pressure and cholesterol and increase their physical activity.
Celldex Therapeutics, Inc. today announced preliminary results from the Company's randomized Phase 2b EMERGE study of CDX-011 (glembatumumab vedotin) antibody drug conjugate in patients with glycoprotein NMB (GPNMB) expressing, advanced, heavily pretreated breast cancer. Preliminary results suggest that CDX-011 induces impressive response rates compared to current, available therapies in patients with advanced, refractory breast cancers with high GPNMB expression.
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that sales of its recently launched over-the-counter pain reliever, Cobroxin, totaled $583,955 for the fourth quarter ending December 31, 2009.
› Verified 9 days ago